This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Title: Kazuki Kuriyama: Innovator in Microneedle Technology
Introduction
Kazuki Kuriyama is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of medical technology, particularly in the development of microneedle systems. With a total of 3 patents to his name, Kuriyama is recognized for his innovative approaches to transdermal drug delivery.
Latest Patents
One of Kuriyama's latest patents is a microneedle sheet production method and microneedle sheet. This method involves preparing a sheet with a first and second surface, making a first cut to define the tip end of the microneedle, and subsequently making a second cut to further refine the microneedle's design. Another notable patent is for a liquid bag designed to store liquid containing an active ingredient for transdermal administration. This liquid bag features a bag body that stores the liquid and directs it toward an injection needle, with a tubular portion that is bent to accommodate the stored liquid.
Career Highlights
Kazuki Kuriyama is currently associated with Hisamitsu Pharmaceutical Company, Inc., where he continues to advance his research and development efforts. His work focuses on enhancing the efficacy and safety of drug delivery systems through innovative technologies.
Collaborations
Kuriyama collaborates with esteemed colleagues such as Seiji Tokumoto and Naoki Yamamoto, contributing to a dynamic research environment that fosters innovation and creativity.
Conclusion
Kazuki Kuriyama's contributions to microneedle technology and transdermal drug delivery systems highlight his role as a leading inventor in the medical field. His innovative patents and collaborative efforts continue to pave the way for advancements in healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile